Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QLS-111 in POAG or OHT (Osprey)
NCT06016972Phase 2Completed
- Start
- Mar 2024
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of QLS-111 in primary open-angle glaucoma (POAG), ocular hypertension. Started Mar 2024; status: completed.
02
Drugs
QLS-111
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT06016972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06016972.